Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | ELANE | P08246 | 5/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.57 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5083344 | 0.87 | KDM4E (1.00) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL10952562 | 0.87 | ELANE (1.00) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL13777324 | 0.84 | KDM4E (0.69) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL11338190 | 0.83 | KDM4E (0.72) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL19140776 | 0.81 | LMNA (0.70) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL17112254 | 0.81 | KDM4E (0.64) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL9751918 | 0.80 | KDM4E (0.63) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL5956271 | 0.80 | KDM4E (0.68) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL11538498 | 0.79 | KDM4E (0.65) | KDM4EPKMELANELMNASMN1; SMN2 | |
| SCHEMBL11597911 | 0.79 | LMNA (0.67) | KDM4EPKMELANELMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008079919-A2 | HEAVY METAL ADSORBENT MATERIAL, PROCESSES OF MAKING THE SAME, AND METHODS OF SEPARATING HEAVY METALS FROM FLUIDS | WORLD MINERALS, INC. (US) | 2008-07-03 | — | — | WO | claimed |
| CN-115524926-A | Method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| US-20090170934-A1 | MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC | NICOX SA | 2009-07-02 | — | — | US | disclosed |
| US-20090096314-A1 | ELECTRIC MOTOR | HONDA MOTOR CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| WO-2008079919-A2 | HEAVY METAL ADSORBENT MATERIAL, PROCESSES OF MAKING THE SAME, AND METHODS OF SEPARATING HEAVY METALS FROM FLUIDS | WORLD MINERALS, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| WO-2008045599-A2 | HEAVY METAL ADSORBENT MATERIAL, PROCESSES OF MAKING SAME, AND METHODS OF SEPARATING HEAVY METALS FROM FLUIDS | WORLD MINERALS, INC. (US) | 2008-04-17 | — | — | WO | disclosed |
| EP-0235728-A2 | Block copolymers having polysiloxane segments | BAYER AG (DE) | 1987-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170934-A1 | MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC | NOS2, NOS1, NOS3 | KDM4E 1339/4885PKM 590/4885ELANE 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.